МИГРЕНЬ БИЛАН КАСАЛЛАНГАН БЕМОРЛАРДА МЕТИЛЕНГИДРОФОЛАТ РЕДУКТАЗА ГЕНИНИНГ ПОЛИМОРФИЗМИДАГИ КЛИНИК ЎЗИГА ХОСЛИК ВА ВЕГЕТАТИВ БУЗИЛИШЛАР
##article.subject##:
мигрен, генотип, аурали мигрен, аурасиз мигрен, МТГФР (метилентетрагидрофолат редуктаза)##article.abstract##
Мигрен билан касалланган 109 та бемор 2 та гуруҳга бўлиниб, аурали мигрен (n-22) ва аурасиз мигрен (n-87) клиник неврологик текширишлар ўтказилди. Бундан ташқари беморларни генотип бўйича тақсимлаш учун ПЗР (полимеразали занжир реакцияси) тадқиқот усули ўтказилди.Тадқиқот натижалари нормал (АА) генотипдан патологик (VV) генотипга қараб, касаллик белгиларининг ўсиб боришини кўрсатади.
Библиографические ссылки
Amelin A.V., Ignatov Yu.D., Skoromets A.A. Migraine (pathogenesis, clinical features and treatment). St. Petersburg Medical Publishing House, 2001; 199.
Wayne A.M., Kolosova O.A., Yakovlev N.A., Slyusar T.A. Migraine. - M., 1995; 180.
Wayne A.M., Kolosova O.A. Headache and migraine // Top. medicine, 1997; 2: 13-16.
Headache. In book: Neurology for general practitioners. Edited by A.M. Wayne. 2nd edition. Eidos Media Publishing House, 2002; 18 - 48.
Gerhard Lybkhokhd. Migraine - a disease of the century // Bulletin of traditional medicine of Russia, 1996; 2: 33-36.
Haulike I. The autonomic nervous system. Trans. from romanian. Bucharest, 1978; 350.
Goadsby P.J., Edvinsson L. The trigeminovacular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats //Ann Neurol, 1993; 33 (1): 48-56.
Diamond S. Migraine Headache. In: Diamond and Dalessio’s the practicing physician’s approach to headache– 6th ed. 1999, 46–71.
Diener H–C., Limmroth V. Prevention migraine: beta–blockers and amine agonists: efficacy. In: Preventive pharmacotherapy of headache disorders. Oxford University Press. 2004; 59–67.
Hademenos G.J., Alberts M.J., Award I. Advances in the genetics of cerebrovascular disease and stroke // Neurology, 2001; 56: 997— 1008.
Rasmussen BK., Jensen R., Schroll M. Epidemiology of headache in a general population – prevalence study. J Clin Epidemiol 1991;44:1147–1157.
Srewart WF., Lipton RB., Celentano DD., Reed ML. Prevalence of migraine headache in the United States. Relation to age, race and other sociodemographic factors. JAMA 1992; 267:64–9.
Stewart W.F., Lipton R.B. Migrain Epidemiology in the United States //Headache Classification and Epidemiolody / J. Olesen, ed. - New York: Raven Press, 1994; 239-247.
Рахимбаева Г.С. Санаева М.Ж. Мигрен ва унинг асоратлари. Тарихга назар // Узбекистон тиббиёт журнали №3 2018г. С.67-72
Abdurakhmonova K.B. Rakhimbaeva G.S. Body mass index and its association with characteristics of migraine // 14th European Headache Federation Congress. Abtractbook. p142.
Abdurakhmonova K.B. Rakhimbaeva G.S. Body mass index and its association with episodic and chronic migraine //14th European Headache Federation Congress. Abtractbook. p36.
Abdurakhmonova K.B., Rakhimbaeva G.S. Effects of depression, anxiety and sleep disturbances on the quality of life in patients with episodic and chronic migraine // 14th European Headache Federation Congress. Abtractbook. p36.
